{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:53:09Z","timestamp":1772632389943,"version":"3.50.1"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Bronchopulmonary dysplasia (BPD) is a common complication among extremely low birth weight Infants. Evidence suggest that the incidence of BPD is increasing. This review examines current evidence-based strategies initiated early in life for prevention of BPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>In this review of early life approaches for prevention of BPD, perinatal interventions, respiratory support strategies, surfactant therapy, pharmacological therapies, fluid management, patent ductus arteriosus management, nutrition, and dietary supplements are discussed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>There is no single effective strategy to prevent BPD in all at risk infants. Therefore, clinicians must use multifaceted evidence-based strategies, beginning during the perinatal period, to reduce the risk of developing BPD in preterm infants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001539","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:01:03Z","timestamp":1768381263000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evidence-based early-post natal approaches to limiting pulmonary disease in extremely low birth weight infants"],"prefix":"10.1097","volume":"38","author":[{"given":"Dinushan C.","family":"Kaluarachchi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Wisconsin-Madison, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colm P.","family":"Travers","sequence":"additional","affiliation":[{"name":"University of Alabama-Birmingham, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik A.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Stanford University, Palo Alto, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"R1-20260304","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpeds.2018.01.043","article-title":"Bronchopulmonary dysplasia: executive summary of a workshop","volume":"197","author":"Higgins","year":"2018","journal-title":"J Pediatr"},{"key":"R2-20260304","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","volume":"5","author":"Bernard","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20260304","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20260304","doi-asserted-by":"crossref","first-page":"130.e1","DOI":"10.1016\/j.ajog.2017.11.554","article-title":"Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids","volume":"218","author":"Travers","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20260304","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/S0140-6736(23)02468-6","article-title":"Deferred cord clamping, cord milking, and immediate cord clamping at preterm birth: a systematic review and individual participant data meta-analysis","volume":"402","author":"Seidler","year":"2023","journal-title":"Lancet"},{"key":"R6-20260304","doi-asserted-by":"crossref","first-page":"e210102","DOI":"10.1001\/jamapediatrics.2021.0102","article-title":"Association of umbilical cord management strategies with outcomes of preterm infants: a systematic review and network meta-analysis","volume":"175","author":"Jasani","year":"2021","journal-title":"JAMA Pediatr"},{"key":"R7-20260304","doi-asserted-by":"crossref","first-page":"e2411140","DOI":"10.1001\/jamanetworkopen.2024.11140","article-title":"Ventilatory assistance before umbilical cord clamping in extremely preterm infants: a randomized clinical trial","volume":"7","author":"Fairchild","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R8-20260304","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jamapediatrics.2024.1848","article-title":"Initial oxygen concentration for the resuscitation of infants born at less than 32 weeks\u2019 gestation: a systematic review and individual participant data network meta-analysis","volume":"178","author":"Sotiropoulos","year":"2024","journal-title":"JAMA Pediatr"},{"key":"R9-20260304","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamapediatrics.2025.2128","article-title":"Deferred cord clamping with high oxygen in extremely preterm infants: a randomized clinical trial","volume":"179","author":"Katheria","year":"2025","journal-title":"JAMA Pediatr"},{"key":"R10-20260304","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1542\/peds.105.6.1194","article-title":"Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network","volume":"105","author":"Van Marter","year":"2000","journal-title":"Pediatrics"},{"key":"R11-20260304","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJMoa072788","article-title":"Nasal CPAP or intubation at birth for very preterm infants","volume":"358","author":"Morley","year":"2008","journal-title":"N Engl J Med"},{"key":"R12-20260304","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1056\/NEJMoa0911783","article-title":"Early CPAP versus surfactant in extremely preterm infants","volume":"362","author":"Finer","year":"2010","journal-title":"N Engl J Med"},{"key":"R13-20260304","doi-asserted-by":"crossref","first-page":"e1069","DOI":"10.1542\/peds.2010-3848","article-title":"Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates","volume":"128","author":"Dunn","year":"2011","journal-title":"Pediatrics"},{"key":"R14-20260304","first-page":"CD001243","article-title":"Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants","volume":"6","author":"Subramaniam","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R15-20260304","doi-asserted-by":"crossref","first-page":"f5980","DOI":"10.1136\/bmj.f5980","article-title":"Noninvasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis","volume":"347","author":"Schm\u00f6lzer","year":"2013","journal-title":"BMJ"},{"key":"R16-20260304","first-page":"CD005384","article-title":"Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants","volume":"12","author":"Lemyre","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20260304","first-page":"CD012712","article-title":"Noninvasive high-frequency ventilation in newborn infants with respiratory distress","volume":"5","author":"Abdel-Latif","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"R18-20260304","first-page":"CD000456","article-title":"Synchronized mechanical ventilation for respiratory support in newborn infants","author":"Greenough","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20260304","first-page":"CD003666","article-title":"Volume-targeted versus pressure-limited ventilation in neonates","volume":"10","author":"Klingenberg","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-20260304","first-page":"CD000104","article-title":"Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants","volume":"3","author":"Cools","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-20260304","doi-asserted-by":"crossref","first-page":"F466","DOI":"10.1136\/adc.2004.068437","article-title":"Ventilation strategies and outcome in randomised trials of high frequency ventilation","volume":"90","author":"Thome","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R22-20260304","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1309220","article-title":"Late outcomes of a randomized trial of high-frequency oscillation in neonates","volume":"370","author":"Zivanovic","year":"2014","journal-title":"N Engl J Med"},{"key":"R23-20260304","first-page":"CD000328","article-title":"Elective high frequency jet ventilation versus conventional ventilation for respiratory distress syndrome in preterm infants","volume":"1998","author":"Bhuta","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20260304","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1542\/peds.100.4.593","article-title":"Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome","volume":"100","author":"Keszler","year":"1997","journal-title":"Pediatrics"},{"key":"R25-20260304","doi-asserted-by":"crossref","first-page":"1392079","DOI":"10.3389\/fped.2024.1392079","article-title":"Outcomes of infants with birthweights less than 501\u200ag compared to infants weighing 501\u2013750\u200ag at a center utilizing first intention high frequency jet ventilation","volume":"12","author":"Elgin","year":"2024","journal-title":"Front Pediatr"},{"key":"R26-20260304","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2018.5725","article-title":"Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration","volume":"319","author":"Askie","year":"2018","journal-title":"JAMA"},{"key":"R27-20260304","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S2213-2600(15)00204-0","article-title":"Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trial","volume":"3","author":"Thome","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"(Pt 1)","key":"R28-20260304","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1542\/peds.104.5.1082","article-title":"Randomized trial of permissive hypercapnia in preterm infants","volume":"104","author":"Mariani","year":"1999","journal-title":"Pediatrics"},{"key":"R29-20260304","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1067\/mpd.2002.127507","article-title":"Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants","volume":"141","author":"Carlo","year":"2002","journal-title":"J Pediatr"},{"key":"R30-20260304","first-page":"CD007836","article-title":"Animal derived surfactant extract for treatment of respiratory distress syndrome","volume":"2009","author":"Seger","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"R31-20260304","first-page":"CD001456","article-title":"Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome","volume":"11","author":"Bahadue","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"R32-20260304","first-page":"CD000141","article-title":"Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome","author":"Soll","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"R33-20260304","first-page":"CD000510","article-title":"Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants","author":"Soll","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"R34-20260304","first-page":"CD000510","article-title":"Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants","author":"Rojas-Reyes","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R35-20260304","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000528914","article-title":"European Consensus guidelines on the management of respiratory distress syndrome \u2013 2022 update","volume":"120","author":"Sweet","year":"2023","journal-title":"Neonatology"},{"key":"R36-20260304","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/archdischild-2022-324184","article-title":"Thresholds for surfactant use in preterm neonates: a network meta-analysis","volume":"108","author":"Branagan","year":"2023","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R37-20260304","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000346460","article-title":"Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences","volume":"104","author":"Dargaville","year":"2013","journal-title":"Neonatology"},{"key":"R38-20260304","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000499674","article-title":"Fraction of inspired oxygen as a predictor of CPAP failure in preterm infants with respiratory distress syndrome: a prospective multi center study","volume":"116","author":"Gulczy\u0144ska","year":"2019","journal-title":"Neonatology"},{"key":"R39-20260304","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/pch\/pxaa116","article-title":"Canadian Paediatric Society. Guidelines for surfactant replacement therapy in neonates","volume":"26","author":"Ng","year":"2021","journal-title":"Paediatr Child Health"},{"key":"R40-20260304","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41372-023-01690-9","article-title":"RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS","volume":"43","author":"Bhandari","year":"2023","journal-title":"J Perinatol"},{"key":"R41-20260304","first-page":"CD011672","article-title":"Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome","volume":"5","author":"Abdel-Latif","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R42-20260304","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.2021.21892","article-title":"Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: the OPTIMIST \u2013 a randomized clinical trial","volume":"326","author":"Dargaville","year":"2021","journal-title":"JAMA"},{"key":"R43-20260304","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.2023.15694","article-title":"Two-year outcomes after minimally invasive surfactant therapy in preterm infants: follow-up of the OPTIMIST \u2013 a randomized clinical trial","volume":"330","author":"Dargaville","year":"2023","journal-title":"JAMA"},{"key":"R44-20260304","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jamapediatrics.2015.0510","article-title":"Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: a systematic review and meta-analysis","volume":"169","author":"Isayama","year":"2015","journal-title":"JAMA Pediatr"},{"key":"R45-20260304","doi-asserted-by":"crossref","first-page":"e2225810","DOI":"10.1001\/jamanetworkopen.2022.25810","article-title":"Association of administration of surfactant using less invasive methods with outcomes in extremely preterm infants less than 27 weeks of gestation","volume":"5","author":"Hartel","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R47-20260304","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine therapy for Apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"N Engl J Med"},{"key":"R48-20260304","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jpeds.2009.09.069","article-title":"Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups","volume":"156","author":"Davis","year":"2010","journal-title":"J Pediatr"},{"key":"R49-20260304","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1164\/rccm.201704-0767OC","article-title":"Neonatal caffeine treatment and respiratory function at 11\u200ayears in children under 1251\u200ag at birth","volume":"196","author":"Doyle","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R50-20260304","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJM199906243402505","article-title":"National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely-low-birth-weight infants","volume":"340","author":"Tyson","year":"1999","journal-title":"N Engl J Med"},{"key":"R51-20260304","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpeds.2021.05.022","article-title":"Should vitamin A injections to prevent bronchopulmonary dysplasia or death be reserved for high-risk infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network randomized trial","volume":"236","author":"Rysavy","year":"2021","journal-title":"J Pediatr"},{"key":"R52-20260304","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/ajcn\/nqab294","article-title":"Vitamin A supplementation in very preterm or very low birth weight infants to prevent morbidity and mortality: a systematic review and meta-analysis of randomized trials","volume":"114","author":"Rakshasbhuvankar","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"R53-20260304","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S2213-2600(24)00073-0","article-title":"Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial","volume":"12","author":"Meyer","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R54-20260304","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/ppul.25230","article-title":"Azithromycin for preventing bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis","volume":"56","author":"Razak","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"R55-20260304","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S2213-2600(24)00079-1","article-title":"Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial","volume":"12","author":"Lowe","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R56-20260304","first-page":"CD000509","article-title":"Inhaled nitric oxide for respiratory failure in preterm infants","volume":"1","author":"Barrington","year":"2017","journal-title":"Cochrane Database of Systematic Rev"},{"key":"R57-20260304","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12887-023-03923-4","article-title":"Inhaled nitric oxide in premature infants for preventing bronchopulmonary dysplasia: a meta-analysis","volume":"23","author":"Zheng","year":"2023","journal-title":"BMC Pediatr"},{"key":"R58-20260304","first-page":"CD001146","article-title":"Early (<7\u200adays) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"10","author":"Doyle","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"R59-20260304","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpeds.2018.10.004","article-title":"Effect of prophylaxis for early adrenal insufficiency using low-dose hydrocortisone in very preterm infants: an individual patient data meta-analysis","volume":"207","author":"Shaffer","year":"2019","journal-title":"J Pediatr"},{"key":"R60-20260304","first-page":"101096","article-title":"Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: a systematic review and meta-analysis","volume":"85","author":"Zhang","year":"2024","journal-title":"Respir Med Res"},{"key":"R61-20260304","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1501917","article-title":"Early inhaled budesonide for the prevention of bronchopulmonary dysplasia","volume":"373","author":"Bassler","year":"2015","journal-title":"N Engl J Med"},{"key":"R62-20260304","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prrv.2025.02.003","article-title":"Efficacy of intratracheal budesonide plus surfactant vs. surfactant alone on bronchopulmonary dysplasia in preterm infants: a meta-analysis of randomized controlled trials","volume":"56","author":"Gomes","year":"2025","journal-title":"Paediatric Respiratory Reviews"},{"key":"R63-20260304","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2024.17380","article-title":"Intratracheal budesonide mixed with surfactant for extremely preterm infants: the PLUSS Randomized Clinical Trial","volume":"332","author":"Manley","year":"2024","journal-title":"JAMA"},{"key":"R64-20260304","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.2025.16450","article-title":"Early intratracheal budesonide to reduce bronchopulmonary dysplasia in extremely preterm infants: the Budesonide in Babies (BiB) randomized clinical trial","volume":"334","author":"Ambalavanan","year":"2025","journal-title":"JAMA"},{"key":"R65-20260304","first-page":"CD000503","article-title":"Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants","volume":"2014","author":"Bell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R66-20260304","first-page":"CD000174","article-title":"Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants","volume":"2010","author":"Fowlie","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R67-20260304","doi-asserted-by":"crossref","first-page":"760029","DOI":"10.3389\/fped.2022.760029","article-title":"Use of prophylactic indomethacin in preterm infants: a systematic review and meta-analysis","volume":"10","author":"Al-Matary","year":"2022","journal-title":"Front Pediatr"},{"key":"R68-20260304","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMoa2207418","article-title":"Expectant management or early ibuprofen for patent ductus arteriosus","volume":"388","author":"Hundscheid","year":"2023","journal-title":"N Engl J Med"},{"key":"R69-20260304","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa2305582","article-title":"Trial of selective early treatment of patent ductus arteriosus with ibuprofen","volume":"390","author":"Gupta","year":"2024","journal-title":"N Engl J Med"},{"key":"R70-20260304","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jamapediatrics.2025.1025","article-title":"Active treatment vs expectant management of patent ductus arteriosus in preterm infants: a meta-analysis","volume":"179","author":"Buvaneswarran","year":"2025","journal-title":"JAMA Pediatr"},{"key":"R71-20260304","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41390-025-03820-9","article-title":"Beneficial vs harmful effects of pharmacological treatment of patent ductus arteriosus: a Bayesian meta-analysis","volume":"98","author":"Villamor","year":"2025","journal-title":"Pediatr Res"},{"key":"R72-20260304","doi-asserted-by":"crossref","first-page":"151721","DOI":"10.1016\/j.semperi.2023.151721","article-title":"Impact of early screening echocardiography and targeted PDA treatment on neonatal outcomes in \u201c22\u201323\u201d week and \u201c24\u201326\u201d infants","volume":"47","author":"Giesinger","year":"2023","journal-title":"Semin Perinatol"},{"key":"R73-20260304","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1164\/rccm.202212-2291OC","article-title":"Impact of early hemodynamic screening on extremely preterm outcomes in a high-performance center","volume":"208","author":"Giesinger","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R74-20260304","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13063-025-08751-8","article-title":"TREOCAPA: prophylactic treatment of the ductus arteriosus in preterm infants by acetaminophen-statistical analysis plan for the randomized phase III group sequential trial","volume":"26","author":"Ursino","year":"2025","journal-title":"Trials"},{"key":"R75-20260304","doi-asserted-by":"crossref","first-page":"e2025071425","DOI":"10.1542\/peds.2025-071425","article-title":"Patent ductus arteriosus in preterm infants","volume":"155","author":"Ambalavanan","year":"2025","journal-title":"Pediatrics"},{"key":"R76-20260304","doi-asserted-by":"crossref","first-page":"F128","DOI":"10.1136\/archdischild-2017-314205","article-title":"Human milk as a protective factor for bronchopulmonary dysplasia: a systematic review and meta-analysis","volume":"104","author":"Huang","year":"2019","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R77-20260304","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/nu10020238","article-title":"Donor human milk protects against bronchopulmonary dysplasia: a systematic review and meta-analysis","volume":"10","author":"Villamor-Mart\u00ednez","year":"2018","journal-title":"Nutrients"},{"key":"R78-20260304","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jama.2023.27693","article-title":"Neurodevelopmental outcomes of extremely preterm infants fed donor milk or preterm infant formula: a randomized clinical trial","volume":"331","author":"Colaizy","year":"2024","journal-title":"JAMA"},{"key":"R79-20260304","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2008.945","article-title":"Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial","volume":"301","author":"Makrides","year":"2009","journal-title":"JAMA"},{"key":"R80-20260304","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1056\/NEJMoa1611942","article-title":"Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infants","volume":"376","author":"Collins","year":"2017","journal-title":"N Engl J Med"},{"key":"R81-20260304","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ajcnut.2025.01.004","article-title":"High-dose docosahexaenoic acid for bronchopulmonary dysplasia severity in very preterm infants: a collaborative individual participant data meta-analysis","volume":"121","author":"Marc","year":"2025","journal-title":"Am J Clin Nutr"},{"key":"R82-20260304","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2021.23580","article-title":"Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013\u20132018","volume":"327","author":"Bell","year":"2022","journal-title":"JAMA"},{"key":"R83-20260304","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.siny.2009.08.004","article-title":"Long-term outcomes of bronchopulmonary dysplasia","volume":"14","author":"Doyle","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"key":"R84-20260304","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1700827","article-title":"Ventilation in extremely preterm infants and respiratory function at 8\u200ayears","volume":"377","author":"Doyle","year":"2017","journal-title":"N Engl J Med"},{"key":"R85-20260304","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00431-017-3009-6","article-title":"The economic impact of prematurity and bronchopulmonary dysplasia","volume":"176","author":"\u00c1lvarez-Fuente","year":"2017","journal-title":"Eur J Pediatr"},{"key":"R86-20260304","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41372-019-0548-x","article-title":"Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life","volume":"40","author":"Lapcharoensap","year":"2020","journal-title":"J Perinatol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:00:42Z","timestamp":1772607642000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001539","relation":{},"ISSN":["1531-698X"],"issn-type":[{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]}}}